4.6 Article

Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

M. J. M. Bonten et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Biotechnology & Applied Microbiology

A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly

S. Dirmesropian et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Article Medicine, General & Internal

US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination

Marie R. Griffin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Cell Biology

Identifying the Interaction Between Influenza and Pneumococcal Pneumonia Using Incidence Data

Sourya Shrestha et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Critical Care Medicine

Incidence and Cost of Pneumonia in Medicare Beneficiaries

Cindy Parks Thomas et al.

Article Medicine, General & Internal

Efficacy of pneumococcal vaccination in adults: a meta-analysis

Anke Huss et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)

Review Medicine, General & Internal

Vaccines for preventing pneumococcal infection in adults

S. A. Moberley et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)

Article Public, Environmental & Occupational Health

Influenza vaccination - Health impact and cost effectiveness among adults aged 50 to 64 and 65 and older

Michael V. Maciosek et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2006)

Article Immunology

Cost-effectiveness of the pneumococcal vaccine in the United States Navy and Marine Corps

PV Pepper et al.

CLINICAL INFECTIOUS DISEASES (2000)